Intracavernosal Needle breakage developed during Self-injection of Vasoactive Agent : Two case reports.
- Author:
Wan LEE
1
;
Jeong Zoo LEE
;
Young Il CHA
;
Gyung Woo JUNG
;
Nam Cheol PARK
Author Information
1. Dr. Cha's Urology Clinic.
- Publication Type:Original Article
- Keywords:
Intracavernous self-injection;
Needle breakage
- MeSH:
Alprostadil;
Drug Therapy;
Erectile Dysfunction;
Male;
Needles*;
Sildenafil Citrate
- From:Korean Journal of Andrology
2000;18(3):225-227
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Currently intracavernous pharmacotherapy is the second common therapeutic modality for erectile dysfunction after the introduction of Viagra. Nevertheless, intracavernous pharmacotherapy has increased in popularity for the past 15 years. While having an overwhelming safety after complete training in injection method, this treatment option can reveal unexpected complications related to self-injection. We report two cases of intracavernous needle breakage associated with alprostadil (Caverject , Pharmacia-Upjohn) and trimix self-injection therapy with a brief review of the literature.
